» Articles » PMID: 17552510

Structure-based Design of Flavonoid Compounds As a New Class of Small-molecule Inhibitors of the Anti-apoptotic Bcl-2 Proteins

Overview
Journal J Med Chem
Specialty Chemistry
Date 2007 Jun 8
PMID 17552510
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Structure-based strategy was employed to design flavonoid compounds to mimic the Bim BH3 peptide as a new class of inhibitors of the anti-apoptotic Bcl-2 proteins. The most potent compound, 4 (BI-33), binds to Bcl-2 and Mcl-1 with Ki values of 17 and 18 nM, respectively. Compound 4 inhibits cell growth in the MDA-MB-231 breast cancer cell line with an IC50 value of 110 nM and effectively induces apoptosis.

Citing Articles

Gossypol with Hydrophobic Linear Esters Exhibits Enhanced Antitumor Activity as an Inhibitor of Antiapoptotic Proteins.

Lu Y, Wu S, Yue Y, He S, Li J, Tang J ACS Med Chem Lett. 2016; 7(12):1185-1190.

PMID: 27994761 PMC: 5150665. DOI: 10.1021/acsmedchemlett.6b00302.


Marinopyrrole derivatives with sulfide spacers as selective disruptors of Mcl-1 binding to pro-apoptotic protein Bim.

Cheng C, Liu Y, Balasis M, Garner T, Li J, Simmons N Mar Drugs. 2014; 12(8):4311-25.

PMID: 25076060 PMC: 4145318. DOI: 10.3390/md12084311.


4,4'-Unsymmetrically substituted 3,3'-biphenyl alpha helical proteomimetics as potential coactivator binding inhibitors.

Weiser P, Chang C, McDonnell D, Hanson R Bioorg Med Chem. 2013; 22(2):917-26.

PMID: 24360824 PMC: 4243926. DOI: 10.1016/j.bmc.2013.10.051.


Structure-based discovery of BM-957 as a potent small-molecule inhibitor of Bcl-2 and Bcl-xL capable of achieving complete tumor regression.

Chen J, Zhou H, Aguilar A, Liu L, Bai L, McEachern D J Med Chem. 2012; 55(19):8502-14.

PMID: 23030453 PMC: 3495162. DOI: 10.1021/jm3010306.


A dual-readout F2 assay that combines fluorescence resonance energy transfer and fluorescence polarization for monitoring bimolecular interactions.

Du Y, Nikolovska-Coleska Z, Qui M, Li L, Lewis I, Dingledine R Assay Drug Dev Technol. 2011; 9(4):382-93.

PMID: 21395401 PMC: 3148108. DOI: 10.1089/adt.2010.0292.


References
1.
Chao D, Korsmeyer S . BCL-2 family: regulators of cell death. Annu Rev Immunol. 1998; 16:395-419. DOI: 10.1146/annurev.immunol.16.1.395. View

2.
Reed J . Bcl-2 family proteins: strategies for overcoming chemoresistance in cancer. Adv Pharmacol. 1997; 41:501-32. DOI: 10.1016/s1054-3589(08)61070-4. View

3.
Minn A, Swain R, Ma A, Thompson C . Recent progress on the regulation of apoptosis by Bcl-2 family members. Adv Immunol. 1998; 70:245-79. DOI: 10.1016/s0065-2776(08)60388-0. View

4.
Oltersdorf T, Elmore S, Shoemaker A, Armstrong R, Augeri D, Belli B . An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 2005; 435(7042):677-81. DOI: 10.1038/nature03579. View

5.
Petros A, Dinges J, Augeri D, Baumeister S, Betebenner D, Bures M . Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis. J Med Chem. 2006; 49(2):656-63. DOI: 10.1021/jm0507532. View